The Latest Breaking News from Johnson & Johnson (

U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78. The Nasdaq added 0.25% to finish at 20,730.49, while the SP 500 advanced 0.3% to 6,263.70.

Johnson & Johnson is back in rally mode after years of post-pandemic normalization and the impact of repositioning, set up to sustain higher prices for years.

U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% on Wednesday.

Johnson Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year over year, beating the consensus of $2.68.

Asian shares are trading mostly lower as worries about President Donald Trump’s latest updates to his tariffs weighed on investor sentiments

A rotation back into value stocks may be imminent in today's market, giving investors a chance to expose themselves into a catch up play.

Hair care should make you look better, not worse. Yet several major shampoo brands are now facing serious legal challenges from consumers who claim these products caused hair loss, scalp irritation, and other injuries. These lawsuits highlight growing concerns about potentially harmful ingredients in everyday hair care products.

Johnson Johnson (NYSE:JNJ) will release earnings results for the second quarter, before the opening bell on Wednesday, July 16.

Johnson & Johnson is set to unveil its Q2 results in the upcoming month, and analysts expect its profitability to observe a notable decline.

Other lives: Non-woven fabrics designer who created new materials for use in industry and agriculture

With earnings season coming to an end, investors are looking for new catalysts; here are three blue-chip companies with strong analyst support